Debt Financing - YS Biopharma

Debt Financing - YS Biopharma

Investment Firm

Overview

YS Biopharma is a global, fully integrated bio-pharmaceutical company.

Announced Date

Mar 23, 2022

Closed on Date

Mar 23, 2022

Funding Type

Debt Financing

Highlights

Location

Asia

Social

Investor Lead

C-Bridge Capital

C-Bridge Capital

C-Bridge Capital is a debt and early_stage_venture and late_stage_venture and private_equity and venture firm.

Participant Investors

1

Investor Name
Participant InvestorC-Bridge Capital

Round Details and Background

YS Biopharma raised $40000000 on 2022-03-23 in Debt Financing

YS Biopharma is a global, fully integrated bio-pharmaceutical company.

Company Funding History

5

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 01, 2012
Venture Round - YS Biopharma
1-undefined
Mar 23, 2022
Debt Financing - YS Biopharma
1-40.0M
Aug 24, 2023
Post-IPO Equity - YS Biopharma
2-671.5K
Feb 09, 2024
Post-IPO Equity - YS Biopharma
-40.0M

Recent Activity

There is no recent news or activity for this profile.